By speaking with 5,250 parents from 7 countries in our global FrieslandCampina survey, we learnt that;
As a result, the market is expanding to include a wide mix of products to address parental concerns.
Directly responding to the demands of today’s parents and care providers, FrieslandCampina Ingredients’ Vana®-Sana DHA and ARA-containing oil products from plant sources are here to help you innovate to satisfy demand and stand-out in the infant milk formula products;
✓Featuring remarkably high oil loads, with 20g DHA and 20g ARA respectively per 100g of powder –almost double the typical concentrations of comparable ingredients. This means formulators can offer more of the benefits of LCPUFAs in their products without extending ingredient labels or significantly increasing ingredient volumes and ensure more sustainable on-pack credentials.
✓ Boast cleaner labels, because dipotassium phosphate (a buffering agent) and silicon dioxide (a flow agent) have been eliminated from our production.
✓ Ensure superb sensory properties, with the help of our advanced micro-encapsulation process through GEA FILTERMAT® technology. DHA and ARA oil is microencapsulated in a powder matrix with significantly less heat load than conventional spray dryers. The process is much gentler and has proven to enhance the nutritional and sensory qualities for consumers and protects the ingredients from environmental conditions during storage, making processing easier for manufacturers.
FrieslandCampina Ingredients has a long history in early life nutrition and can offer insights into the choices parents and carers make. Our knowledge fuels our innovations, including the micro-encapsulation of nutritional oils containing DHA and ARA to meet every consumer expectation. Download our whitepaper now! Together we can accelerate your development process and transform LCPUFAs into early life nutrition product success.
[1] Innis, S. M. (2003). Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. Journal of Pediatrics. https://doi.org/10.1067/s0022-3476(03)00396-2
[2] Innis, S. M. (2007). Dietary (n-3) fatty acids and brain development. In Journal of Nutrition. https://doi.org/10.1093/jn/137.4.855
[3] Drover, J., Hoffman, D. R., Castañeda, Y. S., Morale, S. E., & Birch, E. E. (2009). Three randomized controlled trials of early long-chain polyunsaturated fatty acid supplementation on means-end problem solving in 9-Month-olds. Child Development. https://doi.org/10.1111/j.1467-8624.2009.01339
[4] Drover, J. R., Hoffman, D. R., Castañeda, Y. S., Morale, S. E., Garfield, S., Wheaton, D. H., & Birch, E. E. (2011). Cognitive function in 18-month-old term infants of the DIAMOND study: A randomized, controlled clinical trial with multiple dietary levels of docosahexaenoic acid. Early Human Development. https://doi.org/10.1016/j.earlhumdev.2010.12.047.
[5] DHA and ARA and Visual Development – Scientific Substantiation of a Health Claim Related to Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) and Visual Development Pursuant to Article14 of Regulation (EC) No 1924/2006,” 2009
[6] Lapillonne, A., Pastor, N., Zhuang, W., & Scalabrin, D. M. F. (2014). Infants fed formula with added long chain polyunsaturated fatty acids have reduced incidence of respiratory illnesses and diarrhea during the first year of life. BMC Pediatrics. https://doi.org/10.1186/1471-2431-14-168
[7] Birch, E. E., Khoury, J. C., Berseth, C. L., Castañeda, Y. S., Couch, J. M., Bean, J., Tamer, R., Harris, C. L., Mitmesser, S. H., & Scalabrin, D. M. (2010). The Impact of Early Nutrition on Incidence of Allergic Manifestations and Common Respiratory Illnesses in Children. Journal of Pediatrics. https://doi.org/10.1016/j.jpeds.2010.01.002
"*" indicates required fields